Default object view. Click to create a custom template, Node ID: 169135, Object ID: 101416

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally...

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer

No relation

Yes

No relation

No

08/08/2016 2:58 pm

No